1. Home
  2. ICUI vs CDP Comparison

ICUI vs CDP Comparison

Compare ICUI & CDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • CDP
  • Stock Information
  • Founded
  • ICUI 1984
  • CDP 1988
  • Country
  • ICUI United States
  • CDP United States
  • Employees
  • ICUI N/A
  • CDP N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • CDP Real Estate Investment Trusts
  • Sector
  • ICUI Health Care
  • CDP Real Estate
  • Exchange
  • ICUI Nasdaq
  • CDP Nasdaq
  • Market Cap
  • ICUI 3.4B
  • CDP 3.0B
  • IPO Year
  • ICUI 1992
  • CDP N/A
  • Fundamental
  • Price
  • ICUI $134.86
  • CDP $27.46
  • Analyst Decision
  • ICUI Strong Buy
  • CDP Buy
  • Analyst Count
  • ICUI 5
  • CDP 6
  • Target Price
  • ICUI $196.75
  • CDP $33.50
  • AVG Volume (30 Days)
  • ICUI 283.6K
  • CDP 854.5K
  • Earning Date
  • ICUI 05-08-2025
  • CDP 04-28-2025
  • Dividend Yield
  • ICUI N/A
  • CDP 4.44%
  • EPS Growth
  • ICUI N/A
  • CDP N/A
  • EPS
  • ICUI N/A
  • CDP 1.24
  • Revenue
  • ICUI $2,420,093,000.00
  • CDP $748,556,000.00
  • Revenue This Year
  • ICUI N/A
  • CDP N/A
  • Revenue Next Year
  • ICUI N/A
  • CDP $5.84
  • P/E Ratio
  • ICUI N/A
  • CDP $22.05
  • Revenue Growth
  • ICUI 7.22
  • CDP 5.34
  • 52 Week Low
  • ICUI $101.44
  • CDP $23.84
  • 52 Week High
  • ICUI $196.26
  • CDP $34.22
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 48.47
  • CDP 56.64
  • Support Level
  • ICUI $127.91
  • CDP $27.09
  • Resistance Level
  • ICUI $135.62
  • CDP $27.75
  • Average True Range (ATR)
  • ICUI 4.35
  • CDP 0.46
  • MACD
  • ICUI -0.26
  • CDP 0.04
  • Stochastic Oscillator
  • ICUI 33.77
  • CDP 75.00

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About CDP COPT Defense Properties of Beneficial Interest

COPT Defense Properties is a real estate investment trust that acquires, manages, and leases office and data center properties throughout the U.S. The majority of the company's real estate portfolio is composed of office buildings in the Baltimore-Washington Corridor and Northern Virginia area. COPT derives nearly all of its income in the form of rental revenue from tenants. Most of the company's revenue comes from the leasing of properties to U.S. Government agencies and its contractors in the national security, defense, and IT sectors, such as Northrop Grumman and Boeing. Regional offices in urban submarkets make also make up a sizable percentage of COPT's total square footage.

Share on Social Networks: